Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
8.41B | 7.02B | 6.50B | 5.74B | 4.97B |
Gross Profit | ||||
3.02B | 2.80B | 2.60B | 2.40B | 2.83B |
EBIT | ||||
2.42B | 2.05B | 1.90B | 1.88B | 1.42B |
EBITDA | ||||
2.66B | 2.24B | 2.21B | 2.13B | 1.78B |
Net Income Common Stockholders | ||||
1.02B | 1.19B | 1.48B | 1.25B | 750.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.33B | 1.14B | 1.18B | 1.09B | 1.56B |
Total Assets | ||||
24.63B | 23.39B | 22.75B | 23.25B | 22.78B |
Total Debt | ||||
15.96B | 14.52B | 14.30B | 14.41B | 13.90B |
Net Debt | ||||
14.62B | 13.38B | 13.13B | 13.33B | 12.35B |
Total Liabilities | ||||
19.79B | 18.66B | 18.48B | 19.39B | 19.06B |
Stockholders Equity | ||||
3.11B | 2.87B | 2.50B | 2.24B | 2.17B |
Cash Flow | Free Cash Flow | |||
1.30B | 1.20B | 1.39B | 1.62B | 804.00M |
Operating Cash Flow | ||||
1.50B | 1.32B | 1.49B | 1.73B | 921.00M |
Investing Cash Flow | ||||
-660.00M | 11.00M | -64.00M | -1.10B | -79.00M |
Financing Cash Flow | ||||
-625.00M | -1.37B | -1.31B | -1.09B | -821.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $487.30M | 15.56 | 10.29% | 6.39% | -1.02% | -1.76% | |
76 Outperform | $43.74B | 23.60 | 31.29% | 3.45% | 26.22% | -22.75% | |
74 Outperform | 13.34 | 10.55% | 6.72% | 0.64% | 8.65% | ||
73 Outperform | C$43.38B | 23.30 | 27.52% | 3.45% | 21.63% | -9.39% | |
68 Neutral | $1.04B | 147.72 | 1.11% | 2.62% | 0.33% | -92.77% | |
67 Neutral | 10.84 | 17.96% | 6.25% | -2.67% | -66.51% | ||
61 Neutral | $6.92B | 11.84 | 3.00% | 3.95% | 2.60% | -21.94% |